Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

In the closing of the recent trading day, Pfizer (PFE) stood at $24.70, denoting a +0.65% change from the preceding trading day.

Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of PFE either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my ...

US stock markets showed mixed but slightly positive performance on April 9, 2025, with the Nasdaq leading, up 1.25%.

We recently published a list of 11 Best Innovative Stocks to Buy According to Analysts. In this article, we are going to take a look at where Pfizer Inc.

It's also important for investors to be aware of any recent modifications to analyst estimates for Pfizer. Recent revisions tend to reflect the latest near-term business trends. Hence, positive ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn’t one of them. The 10 stocks that made the cut could ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE ... the effect of tariffs on this ongoing trend has become a major point of dispute in the healthcare business. On February ...

This signals substantial size and strong market recognition. Positive Revenue Trend: Examining Pfizer's financials over ... Analysts typically rate each stock once per quarter.